Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial. [electronic resource]
Producer: 20180611Description: 1630-1636 p. digitalISSN:- 1532-2092
- Aged
- Aged, 80 and over
- Anticoagulants -- administration & dosage
- Antithrombins -- administration & dosage
- Atrial Fibrillation -- complications
- Dabigatran -- administration & dosage
- Defibrillators, Implantable
- Drug Administration Schedule
- Drug Substitution
- Female
- Hematoma -- chemically induced
- Hemorrhage -- chemically induced
- Heparin -- administration & dosage
- Humans
- Male
- Middle Aged
- Pacemaker, Artificial
- Prosthesis Implantation -- adverse effects
- Thrombosis -- etiology
- Time Factors
- Treatment Outcome
- Warfarin -- administration & dosage
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.